Cargando…

The immune score as a new possible approach for the classification of cancer

The outcome prediction in cancer is usually achieved by evaluating tissue samples obtained during surgical removal of the primary tumor focusing on their histopathological characteristics. Tumor staging (AJCC/UICC-TNM classification) summarizes data on tumor burden (T), presence of cancer cells in d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galon, Jérôme, Pagès, Franck, Marincola, Francesco M, Thurin, Magdalena, Trinchieri, Giorgio, Fox, Bernard A, Gajewski, Thomas F, Ascierto, Paolo A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269368/ https://www.ncbi.nlm.nih.gov/pubmed/22214470 http://dx.doi.org/10.1186/1479-5876-10-1

Ejemplares similares

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment
por: Ascierto, Paolo A, et al.
Publicado: (2013)

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study
por: Ascierto, Paolo A., et al.
Publicado: (2020)

World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
por: Galon, Jerome, et al.
Publicado: (2017)

Lean oncology: a new model for oncologists
por: Montesarchio, Vincenzo, et al.
Publicado: (2012)

Combination therapy: the next opportunity and challenge of medicine
por: Ascierto, Paolo A, et al.
Publicado: (2011)

The consensus immunoscore: toward a new classification of colorectal cancer
por: Lanzi, Anastasia, et al.
Publicado: (2020)

What’s new in melanoma? Combination!
por: Ascierto, Paolo A, et al.
Publicado: (2015)

Toward integrative cancer immunotherapy: targeting the tumor microenvironment
por: Emens, Leisha A, et al.
Publicado: (2012)

Melanoma: From Research to Treatment
por: Ascierto, Paolo A., et al.
Publicado: (2011)

Supporting the advancement of science: Open access publishing and the role of mandates
por: Phelps, Lisa, et al.
Publicado: (2012)

Cancer classification using the Immunoscore: a worldwide task force
por: Galon, Jérôme, et al.
Publicado: (2012)

Usefulness and robustness of Immunoscore for personalized management of cancer patients
por: Marliot, Florence, et al.
Publicado: (2020)

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
por: Galon, J., et al.
Publicado: (2016)

Focus on the target: the tumor microenvironment, Society for Immunotherapy of Cancer Annual Meeting Workshop, October 24th-25th 2012
por: Sunay, Melek Erdinc, et al.
Publicado: (2013)

What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014)

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
por: Ascierto, Paolo A., et al.
Publicado: (2015)

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd–5th, 2020, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2021)

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2023)

Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”
por: Ascierto, Paolo A, et al.
Publicado: (2013)

Tumor immunosurveillance in human cancers
por: Mlecnik, Bernhard, et al.
Publicado: (2011)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

Perspectives in melanoma: meeting report from the “Melanoma Bridge” (December 5th–7th, 2019, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2020)

Metastasis immune-based scores predict patient survival
por: Mlecnik, Bernhard, et al.
Publicado: (2020)

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
por: Ascierto, Paolo A, et al.
Publicado: (2011)

The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions
por: Pagès, Franck, et al.
Publicado: (2020)

The influence of diet on anti-cancer immune responsiveness
por: Soldati, Laura, et al.
Publicado: (2018)

Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction
por: Mlecnik, Bernhard, et al.
Publicado: (2010)

The prognostic impact of anti-cancer immune response: a novel classification of cancer patients
por: Bindea, Gabriela, et al.
Publicado: (2011)

Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system?
por: Reizis, Boris, et al.
Publicado: (2011)

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
por: Masucci, Giuseppe V., et al.
Publicado: (2017)

Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
por: Galon, Jérôme, et al.
Publicado: (2014)

The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019
por: Ascierto, Paolo A, et al.
Publicado: (2020)

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
por: Bedognetti, Davide, et al.
Publicado: (2014)

The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2007–08
por: Ablin, Richard J, et al.
Publicado: (2009)

The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2008-09
por: Ablin, Richard J, et al.
Publicado: (2010)

Immunoscore: a new possible approach for melanoma classification
por: Capone, Mariaelena, et al.
Publicado: (2014)

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2019)

Melanoma: the role of surgery in the era of new therapies
por: Mozzillo, Nicola, et al.
Publicado: (2014)

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014
por: Ascierto, Paolo A., et al.
Publicado: (2015)

Classification of Müllerian anomalies: Is a consensus possible?
por: Acién, Maribel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mcad1qo191iflenpjr689qss1j